In human clinical use, reported side effects are generally mild and transient: Mild injection site redness or discomfort (resolves within hours) Transient nausea in some patients, particularly early in the protocol Mild dizziness or light-headedness (rare, typically dose-related) Temporary fatigue in the first few days (often a sign of active tissue remodeling) No significant systemic toxicity, organ damage, hormonal suppression, or addiction potential has been documented in the published literature
TGF-1 (Transforming Growth Factor Beta-1) A protein that, when triggered by androgens, signals hair follicle cells to stop growing a key mechanism in androgenetic alopecia (pattern baldness)
This ensures patients receive treatments that meet rigorous quality and safety standards. Important Safety Information This product is a compounded formulation prepared by a licensed pharmacy pursuant to Section 503A of the Federal Food, Drug, and Cosmetic Act
The milligram numbers are not comparable between the two molecules
-20C, 1 month (sealed storage, away from moisture) Publications (1) Journal Impact Factor Most Recent Solvent & Solubility In Vitro : H 2 O : 100 mg/mL ( 18.66 mM
